Policy Engagement
SWHR provided Representative Diana DeGette (D-CO) and Representative Fred Upton (R-MI) with initial feedback today in response to their recent concept paper addressing the bipartisan planned “Cures 2.0” legislation. The concept paper addresses six key areas Rep. DeGette and Rep. Upton hope to address in follow-up legislation to 2016’s 21st Century Cures Act.
SWHR’s early feedback includes suggested language regarding sex as a biological variable (SABV) in clinical trials research and inclusion of women in research. Feedback also covered on the first section of the concept paper, entitled “National Testing and Response Strategy for Current and Future Pandemics.”
SWHR recommended upcoming Cures 2.0 legislation:
Additionally, SWHR asked the representatives to ensure the National Institutes of Health and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) have adequate authority and funding to implement recommendations related to SABV and clinical trials research.
Related to the ongoing coronavirus pandemic, SWHR recommended that upcoming legislation require states to: